IVD Can Contribute to t-mAb Effectiveness

Therapeutic monoclonal antibodies are useful therapies but in some cases they work for a period, then lose their effectiveness The role of testing in preventing therapeutic monoclonal antibodies from failing has recently received high-profile attention, with a session at AACC and in other places This blog piece by Kalorama analyst Rob Camp, PhD, looks at the role of testing.


Record-Breaking Meeting of IVD and Lab Industry Tackles Key Healthcare Issues

Record-Breaking Meeting of IVD and Lab Industry Tackles Key Healthcare Issues

If there's a problem, find a pathologist. And a lab technician and an IVD company for the equipment. That was the implied message of the world's largest meeting of lab professionals as they tackled the largest challenges in healthcare - opioid addiction, healthcare associated infections (HAIs), near-patient results, autism, Alzheimer's, faster test results, better IT. These were all issues discussed at scientific panels and in vendor booths at the meeting. Kalorama Information was on site and noted the developments at the meeting.


VIDEO: What We'll Be Watching Out for at the #AACC2017 Clinical Expo

VIDEO: What We'll Be Watching Out for at the #AACC2017 Clinical Expo

Test migration, new assays, molecular POC and other trends will be what we are tracking at this year's #AACC2017


What is the Size of the Indonesian IVD Market?

What is the Size of the Indonesian IVD Market?

With a combination of hospitals and community health centers, public and private laboratories, the sprawling Southeast asian nation's rising middle class presages a growing IVD market. This article discusses the Indonesian IVD market, including growth factors and multiple segments.


Brazil Demands More, Fueling IVD Market

Brazil Demands More, Fueling IVD Market

Private healthcare spending can be the difference between a strong market or an under-performing one. In many emerging markets, the first thing to develop once consumers obtain more economic strength is disease detection. That bodes well for the Brazil IVD market.

  • by Bruce Carlson
  • May 2 2017
  • IVD


Back On: Abbott to Acquire Alere, Creating Clear #2 in IVD Industry

Back On: Abbott to Acquire Alere, Creating Clear #2 in IVD Industry

We said last year it would create a POC juggernaut in the IVD market and allow enhance Abbott's competitiveness in infectious disease testing, but the combination of Alere and Abbott was stalled in the courts and with tension between the two companies. Now, to the surprise of many, the deal is back on. Our in vitro diagnostics market reports detail the share of the market that both companies have, both in sales and in test volume.


Earnings Season for IVD: What Does it Say About 2017

Earnings Season for IVD: What Does it Say About 2017

Earnings season is here. Many diagnostic companies are reporting their results for 2016, and some are providing guidance on what they expect for 2017. As might be expected, results for the year 2016 vary greatly among different companies. Kalorama's IVD analysts look into the 2016 revenue report to get a sense of what this means for the coming year.


Top 5 News Stories in IVD - February 2017

Top 5 News Stories in IVD - February 2017

Roche moves into the hematology market with a European product launch, new options come to market for prenatal and newborn screening, and the FDA approves the first commercial Zika test for whole blood samples. Also, scientists design a 1-cent lab-on-a-chip and evidence builds for the power of breath tests to detect a variety of diseases. These are among the top news stories in IVD.

  • by Bruce Carlson
  • January 18 2017
  • IVD


Top 5 News Stories in In Vitro Diagnostics - January 2017

Top 5 News Stories in In Vitro Diagnostics - January 2017

IBM's Watson, new reimbursement rules, Computers bring cancer genomics closer to the clinic, largest liquid biopsy panel eve, DIY paper centrifuges and Zika developments are among the news stories of note for Kalorama this month.


Autoimmune Diagnostics: Analyst Q&A

Autoimmune Diagnostics: Analyst Q&A

What are the main trends in autoimmune testing? What growth rate is expected for revenues, and what are the main companies competing in this important in vitro diagnostic segment. What are the key future trends in AIIVD? We asked these questions of the analyst of Kalorama Information's most recent market research study: Automimmune IVD Testing Markets